针对儿童发作的运动障碍的新兴疗法
Lindsey Vogt1, Vicente Quiroz2, Darius Ebrahimi-Fakhari2,3
1Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto Ontario, Canada.
Current opinion in pediatrics
|April 24, 2024
概括
儿童运动障碍的新疗法正在出现,从症状管理转向精准医学. 这篇评论涵盖了小分子,基因疗法和神经调节,用于诸如图雷特综合征和雷特综合征等疾病.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿童发病的运动障碍传统上是通过症状来管理的.
- 转向基于分子机制的疾病修饰精确疗法.
研究的目的:
- 审查儿童发作的运动障碍的新和新兴疗法.
- 根据治疗实体和治疗方法对审查进行结构化.
主要方法:
- 按治疗实体进行分类:小分子药物,RNA向治疗,基因替代疗法,神经调节.
- 症状和基于分子机制的 (精确) 医学之间的区别.
主要成果:
- 突出了新的小分子药物治疗图雷特综合征,弗里德里希缺氧和雷特综合征.
- 讨论了针对特定遗传疾病的基因疗法进展.
- 探索优化深度大脑刺激和聚焦超声波技术.
结论:
- 精确疗法越来越重要,这是基因进步所推动的.
- 提供了基于分子机制的治疗和临床试验准备的框架.
- 解决开发罕见疾病治疗方法的挑战.
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43


